Literature DB >> 18343521

Injectable, thermo-reversible and complex coacervate combination gels for protein drug delivery.

Kwang-Mi Jin1, Yong-Hee Kim.   

Abstract

Injectable and thermo-reversible physical combination gels were formed in aqueous solution by preparing complex coacervate with two oppositely charged biomacromolecules that composed of negatively charged chondroitin 6-sulfate and positively charged high molecular weight gelatin type A and co-formulating with a negative, thermo-sensitive polysaccharide, methylcellulose containing a salting-out salt, ammonium sulfate. The combination of complex coacervation and a thermo-reversible gel demonstrated synergistic effects on the complex coacervate formation the release rates of model proteins and in situ gel depot formation. Gels indicated sustained release patterns of the protein over 25 days with minimal initial bursts. Optimized novel in situ gel depot systems containing dual advantages of complex coacervation and temperature responsiveness demonstrated a potential for efficient protein drug delivery in terms of high protein loading, sustained protein release, ease of administration, an aqueous environment without toxic organic solvents, and a simple fabrication method.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343521     DOI: 10.1016/j.jconrel.2008.01.015

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  11 in total

1.  Solubility of drugs in aqueous polymeric solution: effect of ovalbumin on microencapsulation process.

Authors:  Hesham Abdul Aziz; Yvonne Tze Fung Tan; Kok Khiang Peh
Journal:  AAPS PharmSciTech       Date:  2011-11-19       Impact factor: 3.246

2.  A convenient method for producing the bleomycin-induced mouse model of scleroderma by weekly injections using a methylcellulose gel.

Authors:  Jae-Bum Jun; Jang Kyoung Kim; Young-In Na; Se Min Jang; Seung Sam Paik; Yong-Hee Kim
Journal:  Rheumatol Int       Date:  2011-03-30       Impact factor: 2.631

Review 3.  IL-1Ra and its delivery strategies: inserting the association in perspective.

Authors:  Muhammad Sajid Hamid Akash; Kanwal Rehman; Shuqing Chen
Journal:  Pharm Res       Date:  2013-06-22       Impact factor: 4.200

4.  A heparin-mimicking reverse thermal gel for controlled delivery of positively charged proteins.

Authors:  Brisa Peña; Robin Shandas; Daewon Park
Journal:  J Biomed Mater Res A       Date:  2014-10-21       Impact factor: 4.396

5.  Low-molecular-weight methylcellulose-based thermo-reversible gel/pluronic micelle combination system for local and sustained docetaxel delivery.

Authors:  Jang Kyoung Kim; Young-Wook Won; Kwang Suk Lim; Yong-Hee Kim
Journal:  Pharm Res       Date:  2011-09-09       Impact factor: 4.200

6.  Driving force and pathway in polyelectrolyte complex coacervation.

Authors:  Shensheng Chen; Zhen-Gang Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-29       Impact factor: 12.779

7.  TAT-Mediated Acidic Fibroblast Growth Factor Delivery to the Dermis Improves Wound Healing of Deep Skin Tissue in Rat.

Authors:  Long Zheng; Qi Hui; Lu Tang; Lulu Zheng; Zi Jin; Bingjie Yu; Zhitao Wang; Peng Lin; Weidan Yu; Haiyan Li; Xiaokun Li; Xiaojie Wang
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

8.  Coacervate Thermoresponsive Polysaccharide Nanoparticles as Delivery System for Piroxicam.

Authors:  Dorota Lachowicz; Agnieszka Kaczyńska; Anna Bodzon-Kulakowska; Anna Karewicz; Roma Wirecka; Michał Szuwarzyński; Szczepan Zapotoczny
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

9.  Fluvastatin influences hair color in C57BL/6 mice.

Authors:  Ryszard Galus; Krzysztof Włodarski; Jacek Malejczyk; Jarosław Jóźwiak
Journal:  Int J Mol Sci       Date:  2013-07-10       Impact factor: 5.923

10.  Ionically Cross-Linked Polymer Networks for the Multiple-Month Release of Small Molecules.

Authors:  Patrick G Lawrence; Pritam S Patil; Nic D Leipzig; Yakov Lapitsky
Journal:  ACS Appl Mater Interfaces       Date:  2016-02-11       Impact factor: 9.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.